1. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
- Author
-
Patel, Nayankumar H., Sardana, Kabir, Shenoy, Manjunath M., Rengasamy, Madhu, Khurana, Ananta, Ghate, Sunil, Venkata, Chalam Konakanchi, Marfatiya, Yogesh, Bhunia, Deblina, Jayaraman, Jyothi, Das, Anupam, and Jain, Akshay Kumar
- Subjects
- *
RINGWORM , *ITRACONAZOLE , *CONTINUING medical education , *ORAL drug administration - Abstract
Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF